The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Mentor Corp.  (MNT) Trade Now »     Rate MNT  -  Discuss MNT  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Medical Equipment & Supplies
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
68.5%
Top:
100.0%
Rate MNT:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

MNT: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Buy MNT (Short-Term Trade) Graphic_rating_buy MNT
-60.63%
in 889 days
<>
  • Rationale: 1) With 16% of its float sold short, or 6,537,400 million shares, with 4.3 days to cover and average daily trading volume (3m) of 888K, it will take 7.36 days to cover the entire position.

  • 2) On a fundamental level MNT is turning around, evident by the fact that inventory levels were 150-170 days for the quarter ending May, vs. 200 and 548 days in 06 and 05. Furthermore, efficient mgmt has led to a shrinking cash conversion cycle, 110 days from 150 and 400 in 06 and 05.

    • <> 3) On April 20th, MNT plunged 5 points on loweri...
    By  Yaser Anwar   (-15.54%  risk: aggressive)  06/04/07 Comment


    MNT is a BUY Graphic_rating_buy MNT
    Fitbusinessmannewsletter
     9 %
    		 -60.40%
    in 931 days
    This is only a short-term opportunistic buy. With last weeks big hit, we now feel the company is closer to it's true value. What can we say, we love taking on injured prey:)


    http://www.mentorcorp.com/global/
    http://investing.reuters.co.uk/news/articleinvesting.aspx?typ...
    http://news.moneycentral.msn.com/provider/providerarticle.asp...

    Mentor Corporation (Mentor) develops, manufactures and markets a range of products serving the aesthetic medicine market, including plastic and reconstructive surgery. Aesthetic surgery products include surgically implant...
    By  FitBusinessman.com   (-24.14%  risk: aggressive)  04/23/07 Comment




    From the Blogosphere

    FDA Calendar: A Weekly Update
    Mikerun
    73%

    <>The accompanying table [click to enlarge] presents an updated calendar of 74 expected FDA decision dates as part of the ETF Innovators [ETFI] New Drug Regulatory Catalyst Index. Below is a summary of the FDA action over the past week.

    1.) ViroPharma (VPHM) – Filed a sBLA on 12/1/08 to expand use of Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema [HAE], which is already FDA approved for regular use in the prevention of angioedema attacks in adolescent and adult patients with HAE. Standard 10-month review target decision date = 10/1/09.

    2.) Questcor...
    By  Mike Havrilla   (+1.04%  risk: conservative)  12/05/08 Comment


    Johnson & Johnson Steals Mentor Corp.: Who's Next?
    <>Last Monday, Johnson & Johnson (JNJ) announced that it had agreed to acquire Mentor (MNT) for $1.07 billion or $31/share, a 92% premium to the prior day’s closing price. While this may sound like a whopping deal for MNT investors, the fact remains that JNJ stole Mentor and likely underpaid for the company. Mentor shares, already down 57% on the year, would have needed to be taken out at a 132% premium simply to match the price level at which they were trading at not too long ago. While another 30-40% on top of JNJ's offer would be great for Mentor’s long term shareholder base, don’t e<>...
    By  trackseekingalpha   (-14.31%  risk: aggressive)  12/08/08 Comment


    FDA Calendar: A Weekly Update
    Mikerun
    73%

    <>The accompanying table [click to enlarge] presents an updated calendar of 74 expected FDA decision dates as part of the ETF Innovators [ETFI] New Drug Regulatory Catalyst Index. Below is a summary of the FDA action over the past week.

    1.) ViroPharma (VPHM) – Filed a sBLA on 12/1/08 to expand use of Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema [HAE], which is already FDA approved for regular use in the prevention of angioedema attacks in adolescent and adult patients with HAE. Standard 10-month review target decision date = 10/1/09.

    2.) Questcor...
    By  Mike Havrilla   (+1.04%  risk: conservative)  12/05/08 Comment


    Bet on T&A with J&J (JNJ) Graphic_rating_buy MNT
    -47.87%
    in 343 days

    Filed under: Deals, Good news, Newsletters, Johnson and Johnson (JNJ), Stocks to Buy

    Over the long holiday weekend, I had a chance to do some much needed reading. Given my vocation, sometimes I like to read articles that have little to do with the markets or finance as a way of recharging my batteries.

    Of course, even when I partake in this guilty pleasure, there really is no way to truly escape. Somehow every story has a link or relationship to investing that I can utilize in my stock-picking mission.

    <>This weekend, it was an article critical of a Shape magazine cover featuring a bikini-clad F...
    By  Jamie Dlugosch   (+19.53%  risk: conservative)  12/01/08 Comment


    Johnson & Johnson (JNJ) buying Mentor (MNT) a good sign

    Filed under: Major movement, Deals, Good news, Industry, Johnson and Johnson (JNJ), Options, Technical Analysis

    JNJ logoJohnson & Johnson (NYSE: JNJ - option chain) shares are lower today after the medical giant announced it would acquire breast implant company Mentor (NYSE: MNT). JNJ put the price for MNT at $31 per share, more than 90% above Friday's price of $16. This kind of buyout activity could signal a couple things. First JNJ is in pretty good financial shape and second that many stocks are undervalued and that resilient companies like JNJ might be looking into making moves in the coming mon...
    By  Brent Archer   (-60.77%  risk: moderate)  12/01/08 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +35.23% 368
    2 Gerald Greene 18.14 +70.19% 206
    3 stockmarketfunding.com 17.66 +25.78% 53
    4 akiralegrand 13.47 +14.32% 61
    5 anup2104 12.13 +69.23% 34


    POPULAR STOCKS
    Symbol Company Name Sentiment
    INTC Intel Corp
    JPM JPMorgan Chase & Co
    XOM Exxon Mobil Corp
    MCD McDonald's Corp.
    DRYS DryShips Inc.
    WFC Wells Fargo & Company

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on MNT

    Visit streetinsider.com


    Discussion Wall + Add  

    Be the first to start a discussion and earn 2 points.



    More Resources

    Graphic_arrow1 About Mentor Corp. - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch